CATALIST-LISTED Singapore Medical Group said on Tuesday that it has exercised its option to convert the convertible loan of US$689,360 granted to CityClinic Asia Investments into 177,670 shares of CCAI at the conversion price of US$3.88 per share.
CCAI is an associate company of SMG incorporated in Singapore and is primarily involved in the business of providing business and management consultancy services, as well as investment holding.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: